Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vacuolar ATPase accessory protein 1 (ATP6AP1) is an accessory subunit of the V-type proton ATPase (V-ATPase), a multi-subunit enzyme complex responsible for acidification of eukaryotic intracellular organelles, which is essential for normal protein sorting, enzyme precursor activation, and receptor-mediated endocytosis. ATP6AP1 helps guide and assemble the V-ATPase complex to its correct subcellular localization, especially in secretory vesicles of neuroendocrine and other regulated cells. Pathogenic variants in ATP6AP1 cause X-linked congenital disorder of glycosylation (CDG), characterized primarily by liver disease, with variable immunodeficiency and connective tissue abnormalities, and less frequently neurologic features. The gene is critical for basic cellular processes via its role in proton transport and membrane dynamics, and defects cause severe multi-organ phenotypes.
Not directly targeted by drugs as a single subunit; however, the V-ATPase complex can be inhibited by small molecules, affecting processes like organelle acidification and trafficking
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vacuolar ATPase accessory protein 1 (ATP6AP1).